Extracellular creatine kinase may modulate purinergic signalling

[1]  A. Zwinderman,et al.  CK (Creatine Kinase) Is Associated With Cardiovascular Hemodynamics , 2020, Hypertension.

[2]  L. Brewster,et al.  Creatine kinase during non-ST-segment elevation acute coronary syndromes is associated with major bleeding , 2020, Open Heart.

[3]  L. Brewster,et al.  Creatine kinase is associated with bleeding after myocardial infarction , 2019, Open Heart.

[4]  E. Wiens,et al.  Routine creatine kinase testing does not provide clinical utility in the emergency department for diagnosis of acute coronary syndromes , 2019, BMC Emergency Medicine.

[5]  L. Brewster,et al.  Creatine Kinase and Blood Pressure: A Systematic Review , 2019, Medical sciences.

[6]  L. Brewster.  Creatine kinase, energy reserve, and hypertension: from bench to bedside. , 2018, Annals of translational medicine.

[7]  A. Gnoni,et al.  Systematic review of plasma-membrane ecto-ATP synthase: A new player in health and disease. , 2018, Experimental and molecular pathology.

[8]  Joseph F. Clark,et al.  Creatine kinase and renal sodium excretion in African and European men on a high sodium diet , 2018, Journal of clinical hypertension.

[9]  L. Brewster.  Creatine kinase: how an obsolete test for skeletal muscle disease became a risk factor for hypertension. , 2017, The Journal of pediatrics.

[10]  Hai-Jian Sun,et al.  NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension , 2017, Cell Death and Disease.

[11]  S. Najib,et al.  Ectopic adenine nucleotide translocase activity controls extracellular ADP levels and regulates the F1-ATPase-mediated HDL endocytosis pathway on hepatocytes. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[12]  L. Brewster,et al.  Creatine kinase as a marker of obesity in a multi-ethnic population , 2017, Molecular and Cellular Endocrinology.

[13]  G. Burnstock.  Purinergic Signaling in the Cardiovascular System. , 2017, Circulation research.

[14]  Joseph F. Clark,et al.  Creatine kinase inhibition lowers systemic arterial blood pressure in spontaneously hypertensive rats: a randomized controlled trial , 2016, Journal of hypertension.

[15]  V. Salomaa,et al.  Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis. , 2015, Circulation research.

[16]  M. Mann,et al.  Deep Proteomics of Mouse Skeletal Muscle Enables Quantitation of Protein Isoforms, Metabolic Pathways, and Transcription Factors* , 2015, Molecular & Cellular Proteomics.

[17]  G. Yegutkin.  Enzymes involved in metabolism of extracellular nucleotides and nucleosides: Functional implications and measurement of activities , 2014, Critical reviews in biochemistry and molecular biology.

[18]  E. Eugenin,et al.  Role of Pannexin-1 hemichannels and purinergic receptors in the pathogenesis of human diseases , 2014, Front. Physiol..

[19]  G. Burnstock,et al.  Purinergic Signaling and Blood Vessels in Health and Disease , 2014, Pharmacological Reviews.

[20]  Joseph F. Clark,et al.  Resistance Artery Creatine Kinase mRNA and Blood Pressure in Humans , 2014, Hypertension.

[21]  M. Billaud,et al.  Mechanisms of ATP release and signalling in the blood vessel wall. , 2012, Cardiovascular research.

[22]  N. Sträter,et al.  Cellular function and molecular structure of ecto-nucleotidases , 2012, Purinergic Signalling.

[23]  S. Joo.  Mechanisms of Platelet Activation and Integrin αIIβ3 , 2012, Korean circulation journal.

[24]  Joseph F. Clark,et al.  Ethnic Differences in Tissue Creatine Kinase Activity: An Observational Study , 2012, PloS one.

[25]  Jian Jin,et al.  AMP Is an Adenosine A1 Receptor Agonist* , 2012, The Journal of Biological Chemistry.

[26]  Yi Fu,et al.  Ectopic ATP synthase in endothelial cells: a novel cardiovascular therapeutic target. , 2010, Current pharmaceutical design.

[27]  J. Lecka,et al.  Extracellular Purine Metabolism in Blood Vessels (Part II): Activity of Ecto-Enzymes in Blood Vessels of Patients With Abdominal Aortic Aneurysm , 2010, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[28]  J. Reijneveld,et al.  Hypertension risk in idiopathic hyperCKemia , 2008, Journal of Neurology.

[29]  L. Brewster,et al.  Distribution of creatine kinase in the general population: implications for statin therapy. , 2007, American heart journal.

[30]  G. L. Kenyon,et al.  Creatine Kinase: Structure‐Activity Relationships , 2006 .

[31]  Joseph F. Clark,et al.  Creatine Kinase Activity Is Associated With Blood Pressure , 2006, Circulation.

[32]  M. Wyss,et al.  Elevated creatine kinase activity in primary hepatocellular carcinoma , 2005, BMC gastroenterology.

[33]  S. Kunapuli,et al.  Central role of the P2Y12 receptor in platelet activation. , 2004, The Journal of clinical investigation.

[34]  C. Bouchard,et al.  Skeletal muscle characteristics predict body fat gain in response to overfeeding in never-obese young men. , 2002, Metabolism: clinical and experimental.

[35]  T. Wallimann,et al.  Divergent Enzyme Kinetics and Structural Properties of the Two Human Mitochondrial Creatine Kinase Isoenzymes , 2000, Biological chemistry.

[36]  G. Vassort,et al.  Interstitial ATP level and degradation in control and postmyocardial infarcted rats. , 1998, American journal of physiology. Cell physiology.

[37]  T D Wood,et al.  Sequence verification of human creatine kinase (43 kDa) isozymes by high-resolution tandem mass spectrometry. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Wyss,et al.  Mitochondrial creatine kinase from chicken brain. Purification, biophysical characterization, and generation of heterodimeric and heterooctameric molecules with subunits of other creatine kinase isoenzymes. , 1990, The Journal of biological chemistry.

[39]  V. Saks,et al.  Protection of ischemic myocardium by exogenous phosphocreatine (neoton): pharmacokinetics of phosphocreatine, reduction of infarct size, stabilization of sarcolemma of ischemic cardiomyocytes, and antithrombotic action. , 1986, Biochemical medicine and metabolic biology.

[40]  D. Jones,et al.  Plasma creatine kinase changes after eccentric and concentric contractions , 1986, Muscle & nerve.

[41]  V A Saks,et al.  Studies of energy transport in heart cells. Mitochondrial isoenzyme of creatine phosphokinase: kinetic properties and regulatory action of Mg2+ ions. , 1975, European journal of biochemistry.

[42]  G. Burnstock.  Introduction to Purinergic Signaling. , 2020, Methods in molecular biology.

[43]  Marko Vendelin,et al.  The creatine kinase phosphotransfer network: thermodynamic and kinetic considerations, the impact of the mitochondrial outer membrane and modelling approaches. , 2007, Sub-cellular biochemistry.

[44]  W. Ellington,et al.  Early evolution of the creatine kinase gene family and the capacity for creatine biosynthesis and membrane transport. , 2007, Sub-cellular biochemistry.

[45]  J. Lindéna,et al.  Kinetic of Adjustment of Enzyme Catalytic Concentrations in the Extracellular Space of the Man, the Dog and the Rat. Approach to a Quantitative Diagnostic Enzymology, V. Communication , 1986, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[46]  J. Knudsen,et al.  Changes in Platelet Functions, Coagulation and Fibrinolysis in Uncomplicated Cases of Acute Myocardial Infarction , 1979, Thrombosis and Haemostasis.